Literature DB >> 20621347

Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients.

Douglas R McDonald1, Frederick Goldman, Oscar D Gomez-Duarte, Andrew C Issekutz, Dinakantha S Kumararatne, Rainer Doffinger, Raif S Geha.   

Abstract

BACKGROUND: IL-1 receptor-associated kinase 4 (IRAK-4) is an effector of the Toll-like receptor and IL-1 receptor pathways that plays a critical role in innate immune responses. The role of IRAK-4 in adaptive immune functions in human subjects is incompletely understood.
OBJECTIVE: We sought to evaluate T-cell function in IRAK-4 deficient patients.
METHODS: We compared upregulation of CD25 and CD69 on T cells and production of IL-2, IL-6, and IFN-gamma after stimulation of PBMCs from 4 IRAK-4-deficient patients and healthy control subjects with anti-CD3 and anti-CD28.
RESULTS: Upregulation of CD25 and CD69 on T cells and production of IL-6 and IFN-gamma, but not IL-2, was significantly reduced in IRAK-4-deficient patients.
CONCLUSIONS: IRAK-4-deficient patients have defects in T-cell activation. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  CD25; CD69; IFNγ; IL-2; IL-6; IRAK-4; T cell; T cell receptor; TNFα; cytokines

Mesh:

Substances:

Year:  2010        PMID: 20621347      PMCID: PMC2917474          DOI: 10.1016/j.jaci.2010.05.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  27 in total

Review 1.  Toll-like receptors; their physiological role and signal transduction system.

Authors:  O Takeuchi; S Akira
Journal:  Int Immunopharmacol       Date:  2001-04       Impact factor: 4.932

Review 2.  Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.

Authors:  L A J O'Neill
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency.

Authors:  Gerben Bouma; Rainer Doffinger; Smita Y Patel; Emma Peskett; Joanna C Sinclair; Gabriela Barcenas-Morales; Lourdes Cerron-Gutierrez; Dinakantha S Kumararatne; E Graham Davies; Adrian J Thrasher; Siobhan O Burns
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

4.  A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.

Authors:  Elisabetta Volpe; Nicolas Servant; Raphaël Zollinger; Sofia I Bogiatzi; Philippe Hupé; Emmanuel Barillot; Vassili Soumelis
Journal:  Nat Immunol       Date:  2008-05-04       Impact factor: 25.606

5.  IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.

Authors:  Elizabeth Lye; Salim Dhanji; Thomas Calzascia; Alisha R Elford; Pamela S Ohashi
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

6.  Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.

Authors:  Frederick D Goldman; Rajeev Vibhakar; Jennifer M Puck; Stephen E Straus; Zuhair K Ballas; Clay Hollenback; Thomas Loew; Anthony Thompson; Kejing Song; Robert T Cook
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

Review 7.  An overview of IL-17 function and signaling.

Authors:  Sarah L Gaffen
Journal:  Cytokine       Date:  2008-08-12       Impact factor: 3.861

8.  IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Authors:  Liang Zhou; Ivaylo I Ivanov; Rosanne Spolski; Roy Min; Kevin Shenderov; Takeshi Egawa; David E Levy; Warren J Leonard; Dan R Littman
Journal:  Nat Immunol       Date:  2007-06-20       Impact factor: 25.606

Review 9.  Transcriptional regulation of Th17 cell differentiation.

Authors:  Ivaylo I Ivanov; Liang Zhou; Dan R Littman
Journal:  Semin Immunol       Date:  2007-11-28       Impact factor: 11.130

10.  Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.

Authors:  Ludovic de Beaucoudrey; Anne Puel; Orchidée Filipe-Santos; Aurélie Cobat; Pegah Ghandil; Maya Chrabieh; Jacqueline Feinberg; Horst von Bernuth; Arina Samarina; Lucile Jannière; Claire Fieschi; Jean-Louis Stéphan; Catherine Boileau; Stanislas Lyonnet; Guillaume Jondeau; Valérie Cormier-Daire; Martine Le Merrer; Cyrille Hoarau; Yvon Lebranchu; Olivier Lortholary; Marie-Olivia Chandesris; François Tron; Eleonora Gambineri; Lucia Bianchi; Carlos Rodriguez-Gallego; Simona E Zitnik; Julia Vasconcelos; Margarida Guedes; Artur Bonito Vitor; Laszlo Marodi; Helen Chapel; Brenda Reid; Chaim Roifman; David Nadal; Janine Reichenbach; Isabel Caragol; Ben-Zion Garty; Figen Dogu; Yildiz Camcioglu; Sanyie Gülle; Ozden Sanal; Alain Fischer; Laurent Abel; Birgitta Stockinger; Capucine Picard; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  6 in total

Review 1.  Advances in basic and clinical immunology in 2010.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

2.  Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.

Authors:  Zhaoyang Li; Kenisha Younger; Ronald Gartenhaus; Ann Mary Joseph; Fang Hu; Maria R Baer; Patrick Brown; Eduardo Davila
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

3.  Protective effect of diallyl trisulfide on liver in rats with sepsis and the mechanism.

Authors:  Huawen Chen; Wei Zhu; Jun Feng; Shusheng Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10

4.  Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease.

Authors:  Satomi Matsuoka; Daigo Hashimoto; Masanori Kadowaki; Hiroyuki Ohigashi; Eiko Hayase; Emi Yokoyama; Yuta Hasegawa; Takahiro Tateno; Xuanzhong Chen; Kazutoshi Aoyama; Hideyo Oka; Masahiro Onozawa; Kiyoshi Takeda; Koichi Akashi; Takanori Teshima
Journal:  Haematologica       Date:  2019-05-02       Impact factor: 9.941

5.  Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Authors:  Jia Wang; Richard A Urbanowicz; Patrick J Tighe; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

6.  Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction.

Authors:  Zhen Wang; Fan-Lian Zeng; Ya-Wen Hu; Xiao-Yan Wang; Fu-Lei Zhao; Pei Zhou; Jing Hu; Yuan-Yuan Xiao; Zhong-Lan Hu; Ming-Feng Guo; Xiao-Qiong Wei; Xiao Liu; Nong-Yu Huang; Jun Zhang; Shu-Wen Chen; Juan Cheng; Hua-Ping Zheng; Hong Zhou; Qi-Xiang Zhao; Chen Zhang; Yan Hao; Song Zou; Yi-Yue Gui; Jia-Dong Yu; Lin-Na Gu; Cheng-Cheng Yue; Hao-Zhou Zhang; Wen-Ling Wu; Yi-Fan Zhou; Xi-Kun Zhou; Guo-Bo Shen; Xiu Teng; Jiong Li
Journal:  Signal Transduct Target Ther       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.